Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending January 9, 2004. The report serves to disclose specific changes in directors' interests in the company's Ordinary Shares and American Depositary Receipts (ADRs) during early January 2004.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a disclosure of equity transactions and does not contain financial performance data.
Material Changes
The filing details the following material changes in director interests:
- Dr. J.P. Garnier: Increased interest by 1,014.283 Ordinary Share ADRs at $46.59 per ADR following dividend reinvestment. Additionally, his interest increased by 73 ADRs via the US Retirement Savings Plan at $45.42 per share.
- Dr. T. Yamada: Increased interest by 35 ADRs via the US Retirement Savings Plan at $45.42 per share.
- Employee Trusts: The GlaxoSmithKline Employee Trust transferred 34,508 Ordinary shares to participants in the SmithKline Beecham Employee Share Option Plan 1991. Directors Dr. J-P Garnier and Mr. J D Coombe hold indirect interests in these shares as potential beneficiaries.
- US Retirement Savings Plan Fund: The total number of Ordinary Share ADRs held by the fund increased from 18,647,046 to 18,658,782 at an average price of $45.42.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to reporting statutory changes in director shareholdings.
Investor Verification Checklist
- Verify the total aggregate shareholding of Dr. J.P. Garnier post-transaction.
- Confirm the impact of the 34,508 share transfer from the GSK Trust on the company's treasury stock or authorized share count.
- Review the pricing consistency between the dividend reinvestment ($46.59) and the retirement plan transactions ($45.42).
- Check subsequent filings for any further changes in the US Retirement Savings Plan holdings.